Related Experiment Video
Updated: May 10, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
Minimally Invasive Overactive Bladder Therapy After Prolapse Surgery.
Abigail Shatkin-Margolis1, Lufan Wang2, Farnoosh Nik-Ahd2
1Department of Obstetrics and Gynecology, University of California, San Francisco, CA.
Minimally invasive overactive bladder therapies were used in only 1.9% of older women post-prolapse surgery, despite a high disease prevalence. This highlights a gap in managing overactive bladder symptoms after pelvic organ prolapse repair.
Area of Science:
- Urogynecology
- Geriatric Medicine
- Health Services Research
Background:
- Pelvic organ prolapse (POP) and overactive bladder (OAB) frequently coexist in older women.
- Understanding treatment patterns for OAB following POP surgery is crucial for optimizing patient care.
Purpose of the Study:
- To investigate the utilization of minimally invasive OAB therapies in older women after undergoing POP surgery.
- To identify factors associated with the use of these therapies.
Main Methods:
- Retrospective cohort study of Medicare beneficiaries undergoing POP surgery (2014-2015).
- Primary outcome: new minimally invasive OAB therapy use within 2 years.
- Secondary outcome: new OAB diagnosis.
- Analysis included modified Poisson regression to determine relative risks.
Main Results:
- 1.9% of 58,841 women received minimally invasive OAB therapy post-surgery.
- 9.2% developed a new OAB diagnosis within 2 years.
- Factors increasing therapy use included apical POP surgery, concomitant stress urinary incontinence surgery, pre-existing OAB, and frailty.
Conclusions:
- Rates of minimally invasive OAB therapy are low in older women post-POP surgery.
- A significant proportion of women develop new OAB diagnoses after surgery.
- Further research is needed to understand and improve OAB management in this population.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

